Develop ALDH1 inhibitor For overcoming tumour drug resistance mechanisms and transform the landscape of oncology treatment See our Science Company Advanced BioDesign is a clinical stage biotechnology company founded in Advanced Biodesign is driven by the ambition to treat all patients facing chemotherapy-resistant cancers with elevated levels of ALDH1.    Since its inception in 2010, this…